1.88

4.62% -0.07

Fortress Biotech Inc (FBIO)

Overview News Price History Option Chain Financials Why FBIO Down? Discussions Forecast Stock Split

Fortress Biotech Inc stock is traded at $1.88, with a volume of 99,041. It is down -4.62% in the last 24 hours and up +5.08% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Previous Close:

$1.95

Open:

$1.92

24h Volume:

99,041

Relative Volume:

0.41

Market Cap:

$55.00M

Revenue:

$80.97M

Net Income/Loss:

$-78.31M

P/E Ratio:

-0.1696

EPS:

-11.0849

Net Cash Flow:

$-129.56M

1W Performance:

+4.49%

1M Performance:

+5.08%

6M Performance:

-12.68%

1Y Performance:

+1.64%

1-Day Range:

$1.84

$1.94

1-Week Range:

$1.7971

$1.959

52-Week Range:

$1.325

$2.89

Fortress Biotech Inc Stock (FBIO) Company Profile

Name

Fortress Biotech Inc

Sector

Healthcare (1177)

Industry

Biotechnology (671)

Phone

781-652-4500

Address

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Employee

101

Twitter

@fortressbio

Next Earnings Date

2024-11-12

Latest SEC Filings

FBIO's Discussions on Twitter

Compare FBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBIO Fortress Biotech Inc	1.86	51.16M	80.97M	-78.31M	-129.56M	-11.08
ONC Beone Medicines Ltd Adr	246.84	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	444.23	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.00	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.24	64.44B	14.09B	4.50B	2.96B	39.28

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-15-24	Resumed	ROTH MKM	Buy
Aug-04-22	Initiated	Ladenburg Thalmann	Buy
Oct-02-20	Initiated	The Benchmark Company	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Feb-28-18	Initiated	B. Riley FBR, Inc.	Buy
Jul-11-17	Initiated	Rodman & Renshaw	Buy
Mar-22-17	Initiated	JMP Securities	Mkt Outperform
Oct-03-16	Initiated	ROTH Capital	Buy

View All

Fortress Biotech Inc Stock (FBIO) Latest News

11:28 AM

Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com

11:28 AM

11:12 AM

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus

11:12 AM

10:51 AM

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewswire

10:51 AM

10:47 AM

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga

10:47 AM

Fortress Biotech Cashes In: $28M Upfront Plus Royalties in Strategic Checkpoint Sale to Sun Pharma - Stock Titan

10:47 AM

May 29, 2025

One Fortress Biotech Insider Raised Stake By 26% In Previous Year - simplywall.st

May 29, 2025

May 28, 2025

Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News

May 28, 2025

May 27, 2025

New Strong Sell Stocks for May 16th - The Globe and Mail

May 27, 2025

May 23, 2025

Q2 EPS Estimates for Fortress Biotech Raised by Roth Capital - Defense World

May 23, 2025

May 22, 2025

How the (FBIOP) price action is used to our Advantage - news.stocktradersdaily.com

May 22, 2025

May 20, 2025

Fortress Biotech Reports Q1 2025 Financial Highlights - TipRanks

May 20, 2025

May 17, 2025

Fortress Biotech First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 17, 2025

May 16, 2025